Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.5225
+0.0110 ( +2.15% ) 9.7K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.5225
Previous close
$0.5115
Volume
9.7K
Market cap
$79.89M
Day range
$0.4960 - $0.5390
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jul 17, 2024 |
| 4 | Insider transactions | 1 | Jul 15, 2024 |
| 4 | Insider transactions | 1 | Jul 08, 2024 |
| 8-k | 8K-related | 13 | Jul 03, 2024 |
| 4 | Insider transactions | 1 | Jul 03, 2024 |
| 4 | Insider transactions | 1 | Jul 03, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |